2021 Alzheimer’s disease facts and figures. Alzheimers Dement. 2021;17(3):327–406. https://doi.org/10.1002/alz.12328.
Sosa-Ortiz AL, Acosta-Castillo I, Prince MJ. Epidemiology of dementias and Alzheimer’s disease. Arch Med Res. 2012;43(8):600–8.
Kamboh MI. Genomics and functional genomics of Alzheimer’s disease. Neurotherapeutics. 2023;19(1):152–72.
Article MathSciNet Google Scholar
Aa R. Risk factors for Alzheimer’s disease. Folia Neuropathol. 2019;57(2):87–105. https://doi.org/10.5114/fn.2019.85929.
Kandimalla R, Reddy PH. Therapeutics of neurotransmitters in Alzheimer’s disease. J Alzheimers Dis. 2017;57(4):1049–69. https://doi.org/10.3233/jad-161118.
Article CAS PubMed PubMed Central Google Scholar
Azargoonjahromi A. Dual role of nitric oxide in Alzheimer’s disease. Nitric Oxide. 2023;134–135:23–37. https://doi.org/10.1016/j.niox.2023.03.003.
Article CAS PubMed Google Scholar
Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT. Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med. 2011;1(1): a006189. https://doi.org/10.1101/cshperspect.a006189.
Article CAS PubMed PubMed Central Google Scholar
Zhang H, Wei W, Zhao M, Ma L, Jiang X, Pei H, et al. Interaction between Aβ and Tau in the Pathogenesis of Alzheimer’s Disease. Int J Biol Sci. 2021;17(9):2181–92. https://doi.org/10.7150/ijbs.57078.
Article CAS PubMed PubMed Central Google Scholar
Terry RD, Davies P. Dementia of the Alzheimer type. Annu Rev Neurosci. 1980;3(1):77–95.
Article CAS PubMed Google Scholar
DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer’s disease. Mol Neurodegener. 2019;14(1):32. https://doi.org/10.1186/s13024-019-0333-5.
Article PubMed PubMed Central Google Scholar
Klein E, Daza NM, Dasgupta I, MacDuffie K, Schönau A, Flynn G, et al. Views of stakeholders at risk for dementia about deep brain stimulation for cognition. Brain Stimul. 2023;16(3):742–7.
Cummings J, Lee G, Ritter A, Sabbagh M, Zhong K. Alzheimer’s disease drug development pipeline: 2020. Alzheimer’s & Dementia: Translational Research & Clinical Interventions. 2020;6(1): e12050.
Yiannopoulou KG, Papageorgiou SG. Current and future treatments in Alzheimer disease: an update. J Cent Nerv Syst Disease. 2020;12:1179573520907397.
Marucci G, Buccioni M, Ben DD, Lambertucci C, Volpini R, Amenta F. Efficacy of acetylcholinesterase inhibitors in Alzheimer’s disease. Neuropharmacology. 2021;190: 108352. https://doi.org/10.1016/j.neuropharm.2020.108352.
Article CAS PubMed Google Scholar
Jackson S, Ham RJ, Wilkinson D. The safety and tolerability of donepezil in patients with Alzheimer’s disease. Br J Clin Pharmacol. 2004;58:1–8.
Article CAS PubMed PubMed Central Google Scholar
Witt A, Macdonald N, Kirkpatrick P. Memantine hydrochloride. Nat Rev Drug Discov. 2004;3(2):109–10.
Article CAS PubMed Google Scholar
Tang B-C, Wang Y-T, Ren J. Basic information about memantine and its treatment of Alzheimer’s disease and other clinical applications. Ibrain. 2023;9(3):340–8. https://doi.org/10.1002/ibra.12098.
Article CAS PubMed PubMed Central Google Scholar
O’Gorman J, Chiao P, Bussière T, von Rosenstiel P, Tian Y, Zhu Y, et al. Clinical Development of Aducanumab, an Anti-Aβ Human Monoclonal Antibody Being Investigated for the Treatment of Early Alzheimer’s Disease. The journal of prevention of Alzheimer’s disease. 2017;4(4):255–63.
Arora S, Santiago JA, Bernstein M, Potashkin JA. Diet and lifestyle impact the development and progression of Alzheimer’s dementia. Front Nutr. 2023. https://doi.org/10.3389/fnut.2023.1213223.
Article PubMed PubMed Central Google Scholar
Cremonini AL, Caffa I, Cea M, Nencioni A, Odetti P, Monacelli F. Nutrients in the prevention of Alzheimer’s disease. Oxid Med Cell Longev. 2019;2019:9874159. https://doi.org/10.1155/2019/9874159.
Article CAS PubMed Google Scholar
Cole GM, Ma QL, Frautschy SA. Omega-3 fatty acids and dementia. Prostaglandins Leukot Essent Fatty Acids. 2009;81(2–3):213–21. https://doi.org/10.1016/j.plefa.2009.05.015.
Article CAS PubMed Google Scholar
Li J, Sun M, Cui X, Li C. Protective effects of flavonoids against Alzheimer’s disease: Pathological hypothesis, potential targets, and structure-activity relationship. Int J Mol Sci. 2022. https://doi.org/10.3390/ijms231710020.
Bukhari SNA. Dietary polyphenols as therapeutic intervention for Alzheimer’s disease: A mechanistic insight. Antioxidants (Basel). 2022. https://doi.org/10.3390/antiox11030554.
Colizzi C. The protective effects of polyphenols on Alzheimer’s disease: A systematic review. Alzheimers Dement (N Y). 2019;5:184–96. https://doi.org/10.1016/j.trci.2018.09.002.
Mielech A, Puścion-Jakubik A, Markiewicz-Żukowska R, Socha K. Vitamins in Alzheimer’s disease-review of the latest reports. Nutrients. 2020. https://doi.org/10.3390/nu12113458.
Zhang L-X, Li C-X, Kakar MU, Khan MS, Wu P-F, Amir RM, et al. Resveratrol (RV): A pharmacological review and call for further research. Biomed Pharmacother. 2021;143: 112164. https://doi.org/10.1016/j.biopha.2021.112164.
Article CAS PubMed Google Scholar
Koushki M, Amiri-Dashatan N, Ahmadi N, Abbaszadeh HA, Rezaei-Tavirani M. Resveratrol: A miraculous natural compound for diseases treatment. Food Sci Nutr. 2018;6(8):2473–90. https://doi.org/10.1002/fsn3.855.
Article CAS PubMed Google Scholar
Tian B, Liu J. Resveratrol: A review of plant sources, synthesis, stability, modification and food application. J Sci Food Agric. 2020;100(4):1392–404. https://doi.org/10.1002/jsfa.10152.
Article CAS PubMed Google Scholar
Goldberg DM, Ng E, Yan J, Karumanchiri A, Soleas G, Diamandis EP. Regional differences in resveratrol isomer concentrations of wines from various cultivars. J Wine Res. 1996;7:13–24.
Ramona C, Olteanu I, Mitruț P, Cichi DD, Cichi M. Study concerning the content in trans and cis—Res veratrol at the grapes Variety. 2007.
Revel G, Hogg TA, Santos CId. Analysis of cis - and trans -resveratrol in Portuguese wines. OENO One. 1996;30:31–7.
Salehi B, Mishra AP, Nigam M, Sener B, Kilic M, Sharifi-Rad M, et al. Resveratrol: a double-edged sword in health benefits. Biomedicines. 2018. https://doi.org/10.3390/biomedicines6030091.
Article PubMed PubMed Central Google Scholar
Sawda C, Moussa C, Turner RS. Resveratrol for Alzheimer’s disease. Ann N Y Acad Sci. 2017;1403(1):142–9.
Article CAS PubMed PubMed Central Google Scholar
Vingtdeux V, Dreses-Werringloer U, Zhao H, Davies P, Marambaud P. Therapeutic potential of resveratrol in Alzheimer’s disease. BMC Neurosci. 2008;9:1–5.
Anekonda TS. Resveratrol—A boon for treating Alzheimer’s disease? Brain Res Rev. 2006;52(2):316–26. https://doi.org/10.1016/j.brainresrev.2006.04.004.
Article CAS PubMed Google Scholar
Jalili C, Kiani A, Gholami M, Bahrehmand F, Fakhri S, Kakehbaraei S, Kakebaraei S. Brain targeting based nanocarriers loaded with resveratrol in Alzheimer’s disease: a review. IET Nanobiotechnol. 2023;17(3):154–70. https://doi.org/10.1049/nbt2.12127.
Article PubMed PubMed Central Google Scholar
Gomes BAQ, Silva JPB, Romeiro CFR, Dos Santos SM, Rodrigues CA, Gonçalves PR, et al. Neuroprotective mechanisms of resveratrol in Alzheimer’s disease: role of SIRT1. Oxid Med Cell Longev. 2018;2018:8152373. https://doi.org/10.1155/2018/8152373.
Article CAS PubMed PubMed Central Google Scholar
Kodali M, Parihar VK, Hattiangady B, Mishra V, Shuai B, Shetty AK. Resveratrol prevents age-related memory and mood dysfunction with increased hippocampal neurogenesis and microvasculature and reduced glial activation. Sci Rep. 2015;5(1):8075. https://doi.org/10.1038/srep08075.
Article CAS PubMed PubMed Central Google Scholar
Farzaei MH, Rahimi R, Nikfar S, Abdollahi M. Effect of resveratrol on cognitive and memory performance and mood: a meta-analysis of 225 patients. Pharmacol Res. 2018;128:338–44.
留言 (0)